HAL-MPE1 / HAL Allergy - LARVOL DELTA

HAL-MPE1 Safety and Tolerability Study (clinicaltrials.gov) - P1; N=42; Completed; Sponsor: HAL Allergy; Active, not recruiting ➔ Completed

Trial completion